Curevac Stock. If we narrow it down even further the data shows that 0 out of 4 analysts rate the stock as a Sell. CVAC has decided to withdraw the companys first-generation COVID-19 vaccine candidate CVnCoV from the current approval process with the.
So far 366189 shares have traded compared to average volume of 629946 shares. 102 rows Discover historical prices for CVAC stock on Yahoo Finance. SEC filings and insider transactions for your stocks.
Curevac Stock Falls Novavax Rises After Covid 19 Vaccine Results Barron S.
CVAC stock price news historical charts analyst ratings and financial information from WSJ. It since hovered around 60 for the rest of August largely held there by the possibility of it. Curevac S Cvncov Phase 2b 3 Study Data Published In Preprints With The Lancet Curevac. CureVacs US shares are listed on the Nasdaq and plunged after hours from 9479 at Wednesdays close to 4954 at Thursdays market open.
